ToPCaP

Dana-Farber Cancer Institute / Brigham and Women's Hospital

Dana-Farber Cancer Institute / Brigham and Women's Hospital

The Department of Radiation Oncology at Dana-Farber/Brigham and Women's Cancer Center plays a central role in treating adults and children with cancer at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Children's Hospital.

The Department of Radiation Oncology also has an active research program that includes both basic (laboratory) and clinical research. Our research often involves collaboration with other departments as we strive to better identify and treat cancer, and to develop ways to deliver higher doses of radiation to the tumor area while reducing the effects to the surrounding healthy tissue.

The DFCI/BWH team is largely made up of pathologists, biostatisticians, and clinicians who provide the necessary expertise and technology to carry out many of ToPCaP's genetic and molecular studies in the area of prostate cancer. In addition, the team is also responsible for leading many small and large projects that seek to identify the key biological markers that can be implemented clinically to refine prostate cancer treatment decisions and to define biomarkers of susceptibility, prediction, and prognosis to impact men's health.